scholarly journals Outcomes of Vismodegib for Periocular Locally Advanced Basal Cell Carcinoma From an Open-label Trial

2020 ◽  
Vol 138 (7) ◽  
pp. 749 ◽  
Author(s):  
Meydan Ben Ishai ◽  
Alon Tiosano ◽  
Eyal Fenig ◽  
Guy Ben Simon ◽  
Iftach Yassur
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Locally Advanced ◽  
Open Label ◽  
Open Label Trial ◽  
Advanced Basal Cell Carcinoma

scholarly journals Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

2017 ◽  
Vol 86 ◽  
pp. 334-348 ◽  
Author(s):  
N. Basset-Séguin ◽  
A. Hauschild ◽  
R. Kunstfeld ◽  
J. Grob ◽  
B. Dréno ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Primary Analysis ◽  
Open Label ◽  
Open Label Trial ◽  
Advanced Basal Cell Carcinoma

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial

2015 ◽  
Vol 16 (6) ◽  
pp. 729-736 ◽  
Author(s):  
Nicole Basset-Seguin ◽  
Axel Hauschild ◽  
Jean-Jacques Grob ◽  
Rainer Kunstfeld ◽  
Brigitte Dréno ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Interim Analysis ◽  
Open Label ◽  
Open Label Trial ◽  
Advanced Basal Cell Carcinoma

Neoadjuvant Vismodegib followed by radiation in locally advanced basal cell carcinoma

2021 ◽  
pp. 100736
Author(s):  
Diya M Sabu ◽  
Jeska Kroes ◽  
Charles Gilham ◽  
Ann Fleming ◽  
Fergal C Kelleher
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Locally Advanced ◽  
Advanced Basal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document